Carditello A
Clinique Chirurgicale, Université de Messine, Italie.
J Chir (Paris). 1990 Jun-Jul;127(6-7):330-3.
To evaluate the results of surgery for nodular thyreopathies, 1300 cases operated on from January 1974 to December 1987 were reviewed. 842 patients (64.7%) were female; the average age, 41 +/- 2.4 year. Thyroid pathology was represented by solitary nodule in 643 cases (49.4%); multinodular goitre in 559 cases (43.0%) (377 euthyroid and 182 hyperthyroid patients); retrosternal in 78 cases (5.9%); recurrent goitre in 20 cases (1.5%). The patients underwent total thyroidectomy (525 cases); sub-total thyroidectomy (132 cases); total lobectomy (643 cases). Post-operative follow-up (clinical exam; T3, T4, tsh analysis); was performed at 3, 6, 12 and 24 months. The overall mortality rate was 0.13 percent (two deaths, respectively after total-0.1% - and sub-total thyroidectomy-0.7%). Immediate post-operative complications were: recurrent palsy (9 cases, 0.6%); acute respiratory failure (2 cases, 0.7%); hypoparathyroidism (3 cases, 0.2%). Late sequelae (1-3 year) were recurrent nerve palsy in 7 patients (0.5%); hypoparathyroidism in one case (0.07%). 46 patients which underwent sub-total thyroidectomy were hypothyroid to T3, T4, TSH analysis and required thyroxine support treatment. New concepts on the pathogenesis of multinodular goitre (growth autonomy of goitre human tissue; failure of thyreosuppressive therapy to prevent relapses after sub-total thyroidectomy) and the results of this review of 1300 interventions seems confirm the indication to total thyroidectomy in the treatment of both euthyroid and toxic multinodular goitre.
为评估结节性甲状腺疾病的手术效果,我们回顾了1974年1月至1987年12月期间接受手术治疗的1300例患者。842例(64.7%)为女性;平均年龄为41±2.4岁。甲状腺病理表现为:643例(49.4%)为孤立性结节;559例(43.0%)为多结节性甲状腺肿(其中377例甲状腺功能正常,182例甲状腺功能亢进);78例(5.9%)为胸骨后甲状腺肿;20例(1.5%)为复发性甲状腺肿。患者接受了甲状腺全切除术(525例);甲状腺次全切除术(132例);甲状腺叶全切除术(643例)。术后随访(临床检查;T3、T4、促甲状腺激素分析)在术后3个月、6个月、12个月和24个月进行。总死亡率为0.13%(两例死亡,分别发生在甲状腺全切除术后-0.1%-和甲状腺次全切除术后-0.7%)。术后即刻并发症有:喉返神经麻痹(9例,0.6%);急性呼吸衰竭(2例,0.7%);甲状旁腺功能减退(3例,0.2%)。晚期后遗症(1-3年)有7例(0.5%)出现喉返神经麻痹;1例(0.07%)出现甲状旁腺功能减退。46例行甲状腺次全切除术的患者经T3、T4、促甲状腺激素分析显示甲状腺功能减退,需要甲状腺素支持治疗。关于多结节性甲状腺肿发病机制的新观点(甲状腺组织生长自主性;甲状腺次全切除术后甲状腺抑制治疗未能预防复发)以及对这1300例手术的回顾结果似乎证实了甲状腺全切除术在治疗甲状腺功能正常和毒性多结节性甲状腺肿方面的适应证。